Type to search

Government News

State Senate passes opioid impact fee

Avatar photo
Share

The state Senate on Tuesday, April 9 passed a bill to impose an impact fee on the sale of opioids. Money collected from the fee would support treatment for those suffering from substance abuse.

The measure, which was approved 17-4, will now go the House. The surcharge would be assessed per milligram morphine equivalent (MME).

“For too long, these companies have reaped record profits while avoiding responsibility for the pain and suffering their products have caused,” said primary sponsor Sen. Hansen, D-Middletown. “With this bill, we will begin holding these companies accountable by forcing them to direct some of that revenue toward breaking the cycle of abuse, addiction and death.”

Republican opponents of the bill say the surcharge will barely put a dent in the problem, and in the meantime pass the additional costs down to patients.

Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2023 Delaware Business Times

Get the DBT Best Restaurants Guide

Your go-to resource for the best places for business meetings, happy hours, power lunches and more, as compiled by the Delaware Business Times editorial team.

No, thank you.
Best Restaurants Cover